Development and Evaluation of Ondansetron Orally Disintegrating Tablets

Anil R Gadhe, Bipin D Pustake, M. Shinde, R. Korhale, V. Gharge
{"title":"Development and Evaluation of Ondansetron Orally Disintegrating Tablets","authors":"Anil R Gadhe, Bipin D Pustake, M. Shinde, R. Korhale, V. Gharge","doi":"10.5920/bjpharm.2018.06","DOIUrl":null,"url":null,"abstract":"Orally disintegrating tablet (ODT) has number of advantages like faster onset of action, ease of administration, rapid disintegration and dissolution etc. A novel attempt has been made to develop orally disintegrating tablets of Ondansetron by using two approaches, one is soluble hydrophilic matrix by superdisintegrant and other is effect of sweetener on the formulation. Direct compression method was employed for making orally disintegrating tablets. The formulated orally disintegrating tablets have rapid disintegration property for better patient compliance. Formulated tablets were evaluated for physical parameters along with wetting time, disintegration time, drug content and “in vitro” dissolution. In first approach it was found that batch F7 containing Crospovidone (Polyplasdone XL 10) 10 mg showed minimum disintegration time (i.e. approx. 7.00 seconds) with maximum drug release. Wetting time for batch F7 was found to beminimum (i.e. 12 seconds). In second approach of selection of sweetener batch F 10 containing Sodium saccharin was found better in terms of Impurity study (Relative Substances study).Impurity was found within the specified limit compared to other two sweeteners. Stability study was carried out on optimized formulation. Overall batch containing 10 mg Crospovidone (Polyplasdone XL 10) along with Sodium Saccharin was foundstable both physically and chemically.","PeriodicalId":9253,"journal":{"name":"British Journal of Pharmacy","volume":"36 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5920/bjpharm.2018.06","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Orally disintegrating tablet (ODT) has number of advantages like faster onset of action, ease of administration, rapid disintegration and dissolution etc. A novel attempt has been made to develop orally disintegrating tablets of Ondansetron by using two approaches, one is soluble hydrophilic matrix by superdisintegrant and other is effect of sweetener on the formulation. Direct compression method was employed for making orally disintegrating tablets. The formulated orally disintegrating tablets have rapid disintegration property for better patient compliance. Formulated tablets were evaluated for physical parameters along with wetting time, disintegration time, drug content and “in vitro” dissolution. In first approach it was found that batch F7 containing Crospovidone (Polyplasdone XL 10) 10 mg showed minimum disintegration time (i.e. approx. 7.00 seconds) with maximum drug release. Wetting time for batch F7 was found to beminimum (i.e. 12 seconds). In second approach of selection of sweetener batch F 10 containing Sodium saccharin was found better in terms of Impurity study (Relative Substances study).Impurity was found within the specified limit compared to other two sweeteners. Stability study was carried out on optimized formulation. Overall batch containing 10 mg Crospovidone (Polyplasdone XL 10) along with Sodium Saccharin was foundstable both physically and chemically.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
昂丹司琼口腔崩解片的研制与评价
口腔崩解片具有起效快、给药方便、崩解快等优点。采用超崩解剂可溶亲水性基质和甜味剂对制剂的影响两种方法制备昂丹司琼口腔崩解片。采用直接压片法制备口腔崩解片。所配制的口腔崩解片具有快速崩解的特性,可提高患者的依从性。对制剂的湿化时间、崩解时间、药物含量、体外溶出度等物理参数进行了评价。在第一种方法中,发现含有10 mg的批F7含crosspovidone (Polyplasdone XL 10)的崩解时间最短(即约为10 mg)。7.00秒),最大药物释放。F7批次的润湿时间最短(即12秒)。在第二种选择方法中,发现含糖精钠的f10批次在杂质研究(相对物质研究)方面表现较好。与其他两种甜味剂相比,杂质含量在规定范围内。对最佳配方进行了稳定性研究。整个批次含有10毫克的crosspovidone (Polyplasdone XL 10)和糖精钠,在物理和化学上都是稳定的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Case Law: A Review of Selected Pharmaceutical Patents Litigated in the UK Courts during 2022 Ensuring Pharmaceutical Product Success through Excipient QbD Efforts Solubility Enhancement for Dietheyldithiocarbamate-Zinc for Lung Cancer Treatment Impact of Critical Material Attributes of HPMC on the Release of Gliclazide from Hydrophilic Matrix Tablets Comparative Evaluation of the Disintegrant Properties of Starches from Three Cultivars of Dioscorea rotundata (Poir)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1